interesting article!
From my reading, these are some of the highlights:
- Concepts development of TAVR during the 90s
- In 1999, a small startup Percutaneous Valve Technologies’ (PVT, NJ, USA) was finally formed to develop the TAVR prototypes
- In 2000, PVT started animal trial on sheep
- In April 2002, PVT performed the first in-human TAVR trial on a 57 y.o. Patient
- While undergoing further TAVR trials and development, Edwards Lifesciences Corporation (Irvine, CA, USA) acquired PVT in 2004 for $155 million. (https://www.google.com.au/amp/s/www.haaretz.com/amp/1.4788606). TAVR entered a new era.
interesting article! From my reading, these are some of the...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.60 | $347.8K | 23.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 760 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.15 | 388 | 1 |
View Market Depth
| Last trade - 15.58pm 30/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |